MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Short-term marketablesecurities$526,563K Cash and cashequivalents$112,825K Prepaid expenses andother current assets$21,366K Contract assets$5,973K Total property andequipment$22,473K Total current assets$666,727K Long-term marketablesecurities$410,297K Right-of-use assets$23,068K Property and equipment,net$8,217K Restricted cash$1,015K Less accumulateddepreciation and...$14,256K Total assets$1,109,324K Total liabilities andstockholders equity$1,109,324K Total stockholdersequity$1,022,934K Total liabilities$86,390K Accumulated deficit-$736,539K Additional paid-in capital$1,757,197K Total currentliabilities$58,815K Long-term operating leaseliabilities$27,575K Accumulated othercomprehensive income$2,267K Common stock, 0.0001par value,...$9K Accrued liabilities$40,892K Accounts payable$17,584K Operating leaseliabilities, current$339K
Balance Sheet
source: myfinsight.com

IDEAYA Biosciences, Inc. (IDYA)

IDEAYA Biosciences, Inc. (IDYA)